OMNIPOD INSULIN PUMP
Report
- Report Number
- 3004464228-2012-00531
- Event Type
- Malfunction
- Date Received
- October 24, 2012
- Date of Event
- September 25, 2012
- Report Date
- September 25, 2012
- Manufacturer
- INSULET CORPORATION
- Product Code
- LZG
- PMA / PMN Number
- K042792
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- NOT APPLICABLE
Narratives
THE POD WAS NOT RETURNED FOR EVALUATION. WE ARE UNABLE TO CONFIRM ANY PRODUCT MALFUNCTION OR DEFECT THAT MAY HAVE CAUSED OR CONTRIBUTED TO THE CUSTOMER'S HIGH BGAS. A DISLODGED CANNULA WOULD LIKELY IMPEDE INSULIN DELIVERY AND MAY LEAD TO HYPERGLYCEMIA. THE LAB, HOWEVER, CANNOT CONFIRM THAT THE CANNULA HAD DISLODGED FROM THE CUSTOMER'S SKIN AND THEREFORE, NO CONCLUSION CAN BE DRAWN. A KINKED CANNULA WOULD LIKELY LEAD TO HYPERGLYCEMIA, HOWEVER, THIS CANNOT BE CONFIRMED SINCE THE DEVICE WAS NOT RETURNED. THE OMNIPOD'S USER GUIDE WARNS TO "CHECK THE INFUSION SITE AFTER INSERTION TO ENSURE THAT THE CANNULA WAS PROPERLY INSERTED. IT IS ALSO A GOOD IDEA TO CHECK YOUR BLOOD GLUCOSE ABOUT TWO HOURS AFTER EACH POD CHANGE AND TO CHECK THE INFUSION SITE PERIODICALLY. IF THE CANNULA IS NOT PROPERLY INSERTED, HYPERGLYCEMIA MAY RESULT." ADDITIONALLY, THE USER GUIDE ADVISES THAT CUSTOMERS CAN AVOID HYPER GLYCEMIA BY CHECKING BLOOD GLUCOSE LEVELS AT LEAST 4 TO 6 TIMES A DAY. AFTER A TOTAL OF 4 HOURS OF MONITORING AND ADMINISTERING CORRECTION BOLUSES, IF BGS STILL REMAIN HIGH THE USER GUIDE INSTRUCTS TO CHANGE THE POD USING A NEW VIAL OF INSULIN AND CONTACT AN HCP FOR GUIDANCE. PRODUCT LOT QUALIFICATION RECORDS WERE REVIEWED AND FOUND TO HAVE MET ALL ACCEPTANCE CRITERIA.
CUSTOMER'S BG ROSE INTO THE 300S MG/DL WHEN SHE REALIZED THE "CANNULA PULLED OUT OF HER SKIN." SHE ALSO REPORTED THE CANNULA APPEARED "KINKED." THE POD IS NOT EXPECTED TO BE RETURNED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | OMNIPOD INSULIN PUMP | PUMP, INFUSINO, INSULIN | LZG | INSULET CORPORATION | 11200 | L30933 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 49 YR |